Chen-Yu Ou – FDA Warning Letter
The FDA issued a Warning Letter to the operators of 366rx.com, rxabode.com, and rxcart.com for offering unapproved and misbranded drugs for sale, violating the Federal Food, Drug, and Cosmetic Act.
The identified violations include the sale of "Xanax (Generic)," "Valium (Generic)," "Viagra (Brand)," "Acomplia (Generic)," "Acomplia (Brand)," "Rimonabant," "Herbal Xanax," and "Herbal Viagra." These products are classified as drugs under section 201(g) of the Act due to their intended use in diagnosis, cure, mitigation, treatment, or prevention of disease, or to affect body structure/function.
Specifically, "Acomplia (Generic)," "Acomplia (Brand)," "Rimonabant," "Herbal Xanax," and "Herbal Viagra" are unapproved new drugs under section 201(p) of the Act. Rimonabant (Acomplia) was previously rejected for FDA approval due to safety concerns, including neurological and psychiatric side effects. The sale of these unapproved drugs violates sections 301(d) and 505(a) of the Act.
Furthermore, products like "Xanax (Generic)," "Valium (Generic)," and "Viagra (Brand)" are misbranded under section 503(b
- Company
- Chen-Yu Ou
- Product type
- Drugs
ID · cb17b700-8e34-4ddf-b36f-62565894369c
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.